Tong Ren Tang Bei Jian: Net profit of 782 million yuan in 2025, a year-over-year increase of 19.81%

2026-03-20 12:35:31

Tasly Biotech announces that in 2025, revenue will be 6.265 billion yuan, a decrease of 8.38% year-on-year. Net profit is 782 million yuan, an increase of 19.81% year-on-year. The company plans to distribute a cash dividend of 4.5 yuan (tax included) for every 10 shares to all shareholders, with no bonus shares and no capital reserve transfer to increase share capital.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.